Tumor ablation is a minimally invasive surgical procedure used to treat solid cancers. Factors such as rising prevalence of different forms of cancer, technological advancements in the field of ablation, rising awareness regarding the benefits offered by ablation procedures over conventional surgical procedures, and rising number of hospitals, surgical and ablation centers are driving the growth of tumor ablation market globally.

The report titled “Tumor Ablation Market - Growth, Future Prospects and Competitive Analysis, 2023–2030” offers strategic insights into the overall tumor ablation market along with the market size and estimates for the duration 2020 to 2030. The research study covers an in-depth analysis of market segments based on technology radiofrequency ablation, microwave ablation, cryoablation, and other technologies, treatment surgical ablation, laparoscopic ablation and percutaneous ablation, application liver cancer, lung cancer, kidney cancer, bone metastasis, and other applications and different geographical regions. 

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers for understanding the ongoing trends in the global tumor ablation market. Tools such as market positioning of key players and attractive investment propositions provide the readers with insights on the competitive scenario of the global tumor ablation market. This report concludes with a company profiles section that highlights major information about the key players engaged in global tumor ablation market. In-depth competitive environment analysis and historical years (2020) of market size data are also provided in the report. Thus, the research study provides a holistic view of the global tumor ablation market, offering market size and estimates for the period from 2020 to 2030, keeping in mind the above-mentioned factors.   

Tumor ablation is a minimally invasive surgical procedure used to treat solid cancers, special probes are used to burn or freeze tumor without performing conventional surgery. These treatments are also sometimes perform in patients waiting for a liver transplant. Factors such as rising prevalence of different forms of cancer, growing number of hospitals, surgical, and ablation centers, technological advancements in ablation devices and growing adoption of tumor ablation procedures are driving the growth of tumor ablation market globally. It is observed that in the base year 2020, radiofrequency ablation held largest market share and it is anticipated that it will grow at highest CAGR during forecast period due to factors such as less risk of tissue damage, widely accepted method for small tumors and faster recovery would influence the growth of radiofrequency ablation market globally. Radiofrequency ablation is commonly used to treat cancer in bone, kidney, liver, lung and prostate.

Ablation refers to removal tissue from the body; tumor ablation is a minimally invasive surgical procedure used to treat solid cancers, special probes are used to burn or freeze tumor without the usual surgery. Factors such as increasing prevalence of different forms of cancer, rising demand for minimally invasive procedures, technological advancements in the field of ablation and rising number of hospitals, surgical and ablation centers are driving the growth of tumor ablation market globally. It is observed that in the base year 2020, surgical ablation held the largest market share due to factors such as rising prevalence of liver and breast cancer and increasing use of thoracoscopic surgical ablation are fueling the growth of surgical ablation market worldwide. There are different types of ablations and various techniques are used to perform the removal of tissue, depending on the nature of the issue. Surgical ablation may be performed with a laser or radio frequency emissions may be used.

Tumor ablation is a minimally invasive procedure that is commonly used in the treatment of tumors of liver, kidney, bone, and lung. Special probes are used to burn or freeze tumor without the usual surgery; these treatments are also sometimes performed in patients waiting for liver transplant. Factors such as rising prevalence of different forms of cancer, technological advancements in ablation devices and growing adoption of tumor ablation procedures are driving the growth of tumor ablation market globally. It is observed that, in the base year 2020, liver cancer is largest revenue generating segment because of increase in prevalence of liver cancer and tumor ablation is globally accepted procedure in treatment of solid tumors in liver for patient where surgical procedure is not possible or preferred. Tumor ablation are also sometimes performed in patients waiting for a liver transplant. Radiofrequency ablation is used primarily to shrink or slow down the growth of liver carcinoma; it is usually done as an outpatient procedure under light sedation.

In the base year 2020, North America dominated the tumor ablation market in terms of revenue and it is anticipated that it will show significant growth during forecast period. The U.S. was observed as the largest country-level market in North America. Factors such as increasing prevalence of different forms of cancer, advanced healthcare infrastructure, higher cost of therapy, technological advances and upsurge funding by the government are the prime contributors to the dominance of North America. It is anticipated that Asia Pacific will grow at the highest CAGR during the forecast period due to developing economic condition, improved treatment access, improvement in awareness among general patient population, rising medical expenditures in emerging economies such as India, China and Japan, growing market penetration of major players in this region would drive the market growth in Asia Pacific during forecast period 2023-2030.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Tumor Ablation market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Tumor Ablation market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Tumor Ablation market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Tumor Ablation market?
• Which is the largest regional market for Tumor Ablation market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Tumor Ablation market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Tumor Ablation market worldwide?